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1. Introduction 
Defects in the atrial septum cause left to right shunt because the left atrial pressure is higher 
than that in the right atrium. This causes volume overloading of the right ventricle. While 
this is generally well tolerated in infancy and childhood, development of exercise 
intolerance and arrhythmias in later childhood and adolescence, and the risk for 
development of pulmonary vascular obstructive disease in adulthood make these defects 
important. There are four major types of atrial septal defects (ASDs) and these include 
ostium secundum, ostium primum, sinus venosus and coronary sinus defects. The clinical 
features are essentially similar and I will present detailed discussion of ostium secundum 
and primum ASDs followed by brief presentation of the other two defects.  
Persistent patency of the foramen ovale in nearly one third of normal population makes the 
patent foramen ovale (PFO) a normal variant, although these become important in the 
presence of other structural abnormalities of the heart and when they become the seat of right 
to left shunt causing paradoxical embolism resulting in stroke/transient ischemic attacks or 
other problems, such as migraine, Caisson’s disease and platypnea-orthodexia syndrome. The 
issues related these types of PFOs will be briefed at the conclusion of this chapter. 
2. Secundum atrial septal defect 
Atrial septal defects constitute 8% to 13% of all congenital heart defects (CHDs). 
Pathologically, there is deficiency of the septal tissue in the region of fossa ovalis. These may 
be small to large. Most of the time, these are single defects, although, occasionally multiple 
defects and fenestrated defects can also be seen. Because of left-to-right shunting across the 
defects, the right atrium and right ventricle are dilated and somewhat hypertrophied. 
Similarly, main and branch pulmonary arteries are also dilated. Pulmonary vascular 
obstructive changes are not usually seen until adulthood. 
Mitral valve abnormalities, including mitral valve prolapse and mitral insufficiency may be 
seen in some patients. It is not clear whether these abnormalities are to due to right 
ventricular volume overloading or intrinsic abnormality of the mitral valve. Pulmonary 
valvar pressure gradients are seen frequently and are thought to be related to increased flow 
and/or differences in expression of kinetic and potential energies in the right ventricle and 
pulmonary artery (Rao et al 1973); however, true pulmonary stenosis is present in only 5% 
of ASD patients. Persistent left superior vena cava may be present in 10% patients. 
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2.1 Clinical features  
The clinical features are essentially similar in all types of ASDs mentioned in the 
Introduction section. 
2.1.1 Symptoms 
Isolated ASD patients are usually asymptomatic and are most often detected at the time of 
preschool physical examination. Sometimes these defects are detected when 
echocardiographic studies are performed for some unrelated reason. A few patients do 
present with symptoms of heart failure in infancy, although this is uncommon. 
2.1.2 Physical examination 
The right ventricular and right ventricular outflow tract impulses are increased and 
hyperdynamic. No thrills are usually felt. The second heart sound is widely split and fixed 
(splitting does not vary with respiration) and is the most characteristic sign of ASD. Ejection 
systolic clicks are rare with ASDs. The ejection systolic murmur of ASD is soft and is of 
grade I-II/VI intensity and rarely, if ever, louder. The murmur is secondary to increased 
blood flow across the pulmonary valve and is heard best at the left upper sternal border. A 
grade I-II/VI mid-diastolic flow rumble is heard (with the bell of the stethoscope) best at the 
left lower sternal border. This is due to large volume flow across the tricuspid valve. There 
is no audible murmur because of flow across the ASD. 
2.2 Noninvasive evaluation 
2.2.1 Chest x-ray  
Chest film usually reveals mild to moderate cardiomegaly, prominent main pulmonary 
artery segment and increased pulmonary vascular markings. 
 
Fig. 1. Chest x-ray in posterior-anterior view demonstrating mild cardiomegaly, increased 
pulmonary vascular markings and a slightly prominent main pulmonary artery segment as 
seen in patients with atrial septal defect. 
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2.2.2 Electrocardiogram  
The ECG shows mild right ventricular hypertrophy; the so-called diastolic volume overload 
pattern with rsR' pattern in the right chest leads. 
 
Fig. 2. An electrocardiogram demonstrating rsR’ pattern in right chest leads, the so called 
diastolic overloading pattern, indicative mild right ventricular hypertrophy, seen in patients 
with atrial septal defects. 
2.2.3 Echocardiogram  
Echocardiographic studies reveal enlarged right ventricle with paradoxical septal motion, 
particularly well-demonstrable on M-mode echocardiograms in patients with moderate to 
large ASDs. Dilatation of the right ventricle may not be present in small defects. By two-
dimensional echocardiogram, the defect can be clearly visualized (Figure 3 left panel).  
 
Fig. 3. Two dimensional subcostal echocardiographic views of the atrial septum 
demonstrating secundum atrial septal defect (ASD) in the mid septum (left panel) and color 
Doppler with left to right shunt (right panel). LA, left atrium; RA, right atrium. 
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The type of ASD, ostium secundum (Figure 3) versus ostium primum (Figure 4) can also be 
delineated by the echocardiographic study.  
 
Fig. 4. Four chambered view of the heart demonstrates ostium primum atrial septal defect 
(ASD), arrow. Note absence of any atrial septal tissue superior to the crest of the ventricular 
septum. The right atrium (RA) and right ventricle (RV) are enlarged. LA, left atrium; LV. left 
ventricle. 
Apical and precordial views may show "septal drop-outs” without an ASD because of 
thinness of the septum in the region of fossa ovalis. Therefore, subcostal views should be 
scrutinized for evidence of ASD. In addition, demonstration of flow across the defect with 
pulsed Doppler and color Doppler (Figure 3, right panel) echocardiography is necessary to 
avoid false positive studies. In adolescents and adults transesophageal echo (TEE) is needed 
to make definitive diagnosis of ASD. (Figures 5 and 6) 
 
Fig. 5. Selected two-dimensional and color flow frame from a transesophageal 
echocardiographic (TEE) study (in adult patient) of the atrial septum shows an atrial septal 
defect (arrow) with left to right shunt (blue flow). Measurements of septal margins (1 Dist and 
3 Dist) and of the defect (2 Dist) are shown in the insert. LA, left atrium; RA, right atrium. 
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Fig. 6. Selected two-dimensional and color flow frame from a transesophageal 
echocardiographic (TEE) study (in another adult patient) of the atrial septum shows multi-
fenestrated atrial septal defect (arrows) with left to right shunt (blue flow). LA, left atrium; 
RA, right atrium. 
2.2.4 Other imaging studies 
Other imaging studies such as three-dimensional echo, MRI and CT can and do demonstrate 
the defect, but are not necessary for routine cases. 
2.3 Catheterization and angiography 
Clinical and echocardiographic features are sufficiently characteristic so that cardiac 
catheterization is not necessary for the diagnosis. However, cardiac catheterization is an 
integral part of transcatheter occlusion of the ASD. 
When catheterization is performed, one will observe step-up in oxygen saturation at the 
right atrial level. The right ventricular or pulmonary arterial saturations may be better to 
estimate the degree of shunting because of improved mixing in these distal sites. The 
pulmonary venous, left atrial, left ventricular and aortic saturations are within normal 
range. In large defects, the pressures in both atria are equal while in small defects, an inter-
atrial pressure difference is noted. The right ventricular and pulmonary arterial pressures 
are usually normal during childhood. Calculated pulmonary-to-systemic flow ratio (Qp:Qs) 
is used to quantify the degree of shunting and a Qp:Qs in excess of 1.5:1 is considered an 
indication for closure of ASD. 
Selective cineangiography in the right upper pulmonary vein at its junction with the left 
atrium in a left axial oblique view will reveal location and the size of the ASD. When 
anomalous pulmonary venous connection is suspected, selective left or right pulmonary 
arterial angiography should be performed and the levophase of angiogram should be 
scrutinized for anomalous pulmonary venous connections.  
To avoid missing a diagnosis of partial anomalous pulmonary venous return, we usually 
perform a number of routine maneuvers and these include (i) measurement of oxygen 
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saturations from both right and left innominate veins at the time of superior vena caval 
sampling, (ii) left innominate vein cineangiogram in posterior-anterior view with diluted 
contrast material, (iii) probe for all the four pulmonary veins from the left atrium and (iv) as 
mentioned before, obtain cineangiography from the right upper pulmonary vein at its 
junction with the left atrium in a left axial oblique (300 LAO and 300 cranial) view. 
2.4 Management 
The management of ASD patients is largely dependent of the age at presentation, presence 
of symptoms, particularly those of congestive heart failure and the size of the defect (and 
magnitude of the shunt).  
2.4.1 Medical management 
As mentioned earlier, congestive heart failure is rare with ASDs, although occasionally, 
failure symptoms may be present in infancy. In these infants anti-congestive measures 
(diuretics and digoxin) should be instituted. If they do not improve, surgical and more 
recently trans-catheter intervention to close the defects are considered.  
Small ASDs, not requiring closure may be followed at infrequent intervals. SBE prophylaxis 
and activity restriction are not generally recommended for ASD patients. 
2.4.2 Indications for closure 
Despite lack of symptoms at presentation, closure of moderate to large ASDs is 
recommended so as to 1) prevent development of pulmonary vascular obstructive disease 
later in life, 2) reduce chances for supra-ventricular arrhythmias and 3) prevent 
development of symptoms during adolescence and adulthood. Elective closure around age 4 
to 5 years is recommended. Closure during infancy is not undertaken unless the infant is 
symptomatic. Right ventricular volume overloading by echocardiogram and a Qp:Qs >1.5 (if 
the child had cardiac catheterization) are indications for closure. 
2.4.3 Surgical management 
Following the introduction of cardiopulmonary bypass techniques for open heart surgery 
and the description of surgical closure of ASD by Gibbon, Lillehei and Kirklin in 1950s, it 
rapidly became a standard treatment for atrial defects. The conventional treatment of choice 
of moderate and large defects until recently is surgical correction. Under general anesthesia, 
a median sternotomy or a right submammary incision is made, the aorta and vena cavae are 
cannulated and the patient placed on cardiopulmonary bypass. Right atriatomy is made and 
the defect exposed and closed either by approximating the defect margins with suture 
material or by using a pericardial patch, depending upon the size of the defect. 
While surgical closure of ostium secundum ASDs is safe and effective with low (<1%) 
mortality, the morbidity associated with sternotomy/thoracotomy, cardiopulmonary bypass 
and potential for postoperative complications cannot be avoided. Other disadvantages of 
surgical therapy are the expense associated with surgical correction, residual surgical scar 
and psychological trauma to the patients and/or the parents. Because of these reasons 
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several trans-catheter methods have been developed (Chopra and Rao, 2000; Rao, 2003) 
which will be reviewed in the next section. 
At the present time, surgical repair is largely reserved for defects with poor septal rims in 
which the interventional cardiologist deems that defect is difficult to close with trans-
catheter methodology or was unsuccessful in closing the defect. Also, if intra-cardiac repair 
of other defects is contemplated, surgical closure of ASD could be performed at the same 
time. 
2.4.4 Trans-catheter closure 
As alluded to above, a large number of devices have been developed over the last three and 
one-half decades. Some of the devices have been discontinued and others modified and 
redesigned (Rao, 1998; Rao, 2000; Rao, 2003b). Clinical trials have been undertaken with a 
large number of devices as reviewed elsewhere (Rao, 2000; Rao, 2003b) and feasibility, safety 
and effectiveness of these devices in occluding the ASD have been demonstrated.  
Clinical trials have been undertaken in a large number of patients with Bard clamshell septal 
occluder and buttoned device and feasibility and effectiveness of these devices in occluding 
the ASD have been demonstrated. Fractures of one or more arms of the clamshell device 
with occasional embolization, has prompted the investigators and the US Food and Drug 
Administration (FDA) to withdraw the device from clinical trials. The buttoned device has 
undergone clinical trials and, immediate and short-term follow-up results are encouraging 
(Rao et al 1992, Rao et al 1994, Rao et al 2000, Rao and Sideris 2001). However, pre-market-
approval (PMA) application was not made and consequently it is not approved by the FDA 
and is not available for general clinical use. Subsequently, a large number of other devices 
(Das Angel-Wing, ASDOS, Amplatzer, CardioSeal, HELEX and others) have been 
introduced and clinical trials began (Chopra and Rao 2000). At the present time however, 
Amplatzer Septal Occluder and HELEX are the only two devices that are approved for 
general clinical use by the FDA. The experience with Amplatzer for most defects has been 
encouraging. HELEX device is only useful in small to medium-sized defects. A number of 
other devices are in clinical trials either in the US or in other countries with local, national or 
regional IRB supervision. These devices, to the best of my knowledge, are 
CardioSeal/StarFlex devices, transcatheter patch, pfm ASD-R device, bio-absorbable NMT 
devices (Bio-STAR and Bio-TREK), Occlutech Flex device, Cardia devices (INTRASEPT, 
ATRIASEPT I/II-ASD and ULTRASEPT), Solysafe Septal Occluder, Heart R Septal Occluder 
(manufactured in China) and others. The Amplatzer Septal Occluder is rapidly becoming 
the device of choice because of ease with which the device can be implanted, retrieved and 
repositioned plus the comfort that the device is FDA approved. 
2.4.4.1 Amplatzer septal occluder 
Amplatzer septal occluder is a double disk device constructed with 0.004" to 0.007" Nitinol 
(nickle-titanium compound) wire with shape memory. A 4 mm wide waist connects the left 
and right atrial disks and stents the ASD. The left atrial disk is slightly larger than the right. 
Dacron polyester patches are sewn into each disk. Multiple sizes are available from the 
manufacturer (AGA); the device size is expressed as the size of waist of the device. The 
device can be withdrawn into a delivery sheath and can be implanted across the defect and 
if necessary pulled back into the sheath and repositioned. 
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2.4.4.1.1 Method of device implantation 
The procedure involves percutaneous right heart catheterization to confirm the clinical and 
echocardiographic diagnosis with particular attention to exclude partial anomalous 
pulmonary venous return. A left atrial cineangiogram in a left axial oblique view (300 LAO 
and 300 Cranial) with the catheter positioned in the right upper pulmonary vein at its 
junction with the left atrium is then performed. This is followed by transesophageal (TEE) or 
intracardiac (ICE) echocardiography to measure the size of the ASD, to visualize entry of all 
pulmonary veins into the left atrium and to examine the atrial septal rims. Static balloon 
sizing of the ASD using NuMed PTS or AGA Amplatzer sizing balloons is performed 
routinely by some cardiologists. During balloon occlusion, color Doppler evaluation of the 
atrial septum to rule out additional atrial defects should be carried out. However, I do not 
routinely perform balloon sizing, but rely on the TEE sizing; I utilize the thick margins of 
the defect to measure the size of the ASD, leaving out the flail margins, a method similar to 
that suggested by Carcagnì and Presbitero (2004). 
An Amplatzer Septal Occluder that is 1 to 2 mm larger than the diameter of the ASD is 
selected for implantation. The size of delivery sheath accommodating the selected device is 
then be positioned in the left upper pulmonary vein, taking appropriate precautions to 
avoid inadvertent air entry into the system. The selected device is screwed onto the delivery 
cable; the device is loosened by unscrewing by one turn and drawn into the loader sheath 
under saline. The device is deposited into the delivery sheath while flushing the loader 
sheath continuously with saline or a similar flushing solution. This is to prevent inadvertent 
air entry into the system. The device is advanced within the sheath under fluoroscopic 
guidance until it reaches the tip of the delivery sheath in the left upper pulmonary vein. It is 
important not to rotate the delivery cable to prevent inadvertent unscrewing of the device. 
The entire system is withdrawn until the tip of the sheath slips into the free left atrium and 
the device advanced, thus releasing the left atrial disk. Under echocardiographic guidance, 
the entire system is withdrawn such that the left atrial disk is flush against the left atrial side 
of the atrial septum occluding the ASD. Then, while the device cable is held steady, the 
delivery sheath is withdrawn releasing the waist of the device within the atrial septal defect, 
followed by further withdrawal of the sheath deploying the right atrial disk in the right 
atrium. The position of the device is verified by echocardiography and residual shunt 
looked for. If the device position is satisfactory, the device cable is moved back and forth (so 
called Minnesota Wiggle). The position of the device is again verified by TEE (or ICE). If the 
device position is unsatisfactory, the device can be withdrawn into the sheath and 
redeployed. Then the device cable is rotated counterclockwise, releasing the device. A 
repeat TEE to ensure good position of the device is undertaken. Right atrial 
cineangiography through the delivery sheath is performed by some cardiologists prior to 
withdrawal of the delivery sheath out of body.  
Arterial line to monitor the systemic pressures throughout the procedure, administration of 
heparin (100 units/kg) and monitoring the ACT to keep it above 200 seconds, and 
administration of Ancef or a similar antibiotic are routine parts of the procedure. Aspirin 5 
mg/kg as a single daily dose for six months is usually recommended. Clopidogrel (Plavix) is 
used in adult patients. 
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2.4.4.1.2 Complex defects 
Large defects, small septal rims, multiple defects and septal aneurysms pose additional 
problems and appropriate adjustments in the technique (Nagm and Rao 2004) should be 
undertaken to ensure success of the device implantation. 
2.4.4.1.3 Results 
Both immediate and mid-term follow-up results of Amplatzer Septal Occluder appear 
excellent with immediate complete closure rates varying from 62% to 96% which improved to 
83% to 99% at six to 12 month follow-up (Hamdan et al 2003). We undertook closure of 80 
ostium secundum defects with this device; there was a small residual shunt in two patients at 
the conclusion of the procedure. This shunt disappeared at one and six month follow-up visits 
respectively. No residual shunts were observed during a mean follow-up of 24 months. 
2.4.4.2 HELEX device 
HELEX device is constructed with a single stand super-elastic, Nitinol wire frame with 
ultrathin poly-tetra-fluro-ethelene (ePTFE) covering the entire length of the wire; the device 
can be loaded into a 9-F delivery sheath. The delivery system has three components, a 
delivery catheter, control catheter and a mandrel. When deployed, it forms two 
interconnected round disks, designed to be placed on either side of the atrial septum. The 
device is available in 15 thru' 35 mm diameter sizes in 5 mm increments.  
2.4.4.2.1 Method of device implantation 
The procedures of catheterization and defect sizing are similar those described in Amplatzer 
device section. The method of implantation is detailed elsewhere (Latson et al 2003). In brief, 
the delivery catheter (Green) is placed in the left atrium over a guide wire and the wire 
removed. Push-pinch-pull method is used to form the left atrial disk and the disk pulled 
back gently to engage the left side of the atrial septum, under fluoroscopic and/or TEE or 
ICE guidance. Then the delivery (Green) catheter is withdrawn over the control (Gray) 
catheter until the mandrel (Tan) engages the hub. Then the green catheter is held study 
while the gray catheter is advanced to deliver the right atrial disk on the right atrial side of 
the septum, again using the "push-pinch-pull" technique. Once the device position is 
verified by echocardiography (TEE or ICE), the device is locked and then released. Intra and 
post procedural management is similar to that described in the Amplatzer device section.  
2.4.4.2.2 Results 
Results of the multicenter trial (Jones et al 2007) suggest successful implantation in 87% 
patients with low incidence of residual leaks (2.6% at one year follow-up) and modest 
incidence (8%) of wire frame fractures. It is generally considered to be a good device for 
occlusion of small to medium-sized ASDs. 
2.5 Prognosis 
The prognosis following surgical or transcatheter closure of ASDs is excellent, provided that 
they do not have pulmonary hypertension or atrial tachycardia. Actuarial survival rate 
following surgery were 97%, 90%, 83% and 74% at 5, 10, 20 and 30 years respectively 
(Murphy et al 1990) and were slightly worse than that of control (normal) population (99%, 
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98%, 94% & 85%). However, if surgical correction is performed prior to 25 years of age, the 
actuarial survival rates are similar to normal population. Similar favorable results can be 
expected if the defect is closed by trans-catheter methodology prior to 25 years of age. 
3. Ostium primum ASDs 
Ostium primum ASDs belong to the group of defects called atrio-ventricular septal defects 
(AVSDs) and are thought to be caused by defective embryonic development of embryonic 
endocardial cushions. There is persistence of the embryonic ostium primum, located in the 
posterior portion of the lower part of the atrial septum, usually large in size. A cleft in the 
anterior leaflet of the mitral valve is present, causing mitral insufficiency of varying degree. 
Depending upon the direction of mitral insufficiency jet, there may be a left ventricular-to-
right atrial shunt as well. A cleft in the septal leaflet of the tricuspid valve may be present in 
some patients. These defects are formerly known as partial endocardial cushion defects. 
These defects are also called partial AVSDs; this is in contradistinction to complete AVSDs 
in which atrial and ventricular septal defects and clefts in the mitral and tricuspid valves 
with common atrio-ventricular valve are present. There may be associated ostium 
secundum ASD, patent foramen ovale or a persistent left superior vena cava draining into 
the coronary sinus. 
The left ventricular outflow tract is long and narrow and sometimes the abnormal 
attachments of the atrio-ventricular valve tissue may cause left ventricular outflow tract 
obstruction. 
Dilatation of the right heart structures is similar to that described for ostium secundum 
atrial septal defects. In the presence moderate to severe mitral insufficiency left ventricular 
dilatation may also be present. 
3.1 Clinical features  
The clinical features are essentially similar to that described for ostium secundum ASDs; 
however in the presence of significant mitral insufficiency symptoms of heart failure may be 
present.  
3.1.1 Symptoms 
Isolated ostium primum ASD patients are usually asymptomatic and are most often 
detected at the time of preschool physical examination. However, murmurs associated with 
mitral insufficiency of ostium primum defects may also result in early detection of these 
defects. A few patients do present with symptoms of heart failure in infancy or childhood 
especially in the presence of significant mitral insufficiency. 
3.1.2 Physical examination 
The right ventricular and right ventricular outflow tract impulses are increased and 
hyperdynamic. No thrills are usually felt. The second heart sound is widely split and fixed 
(splitting does not vary with respiration) and is the most characteristic sign of ASD. Ejection 
systolic clicks are rare with ASDs. The ejection systolic murmur of ASD is soft and is of 
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grade I-II/VI intensity and rarely, if ever, louder. The murmur is secondary to increased 
blood flow across the pulmonary valve and is heard best at the left upper sternal border. A 
grade I-II/VI mid-diastolic flow rumble is heard (with the bell of the stethoscope) best at the 
left lower sternal border. This is due to large volume flow across the tricuspid valve. There 
is no audible murmur because of flow across the ASD. A holosystolic murmur of mitral 
insufficiency is heard best at the apex with radiation into the anterior and/or mid axillary 
line. A grade I-II/VI mid-diastolic flow rumble, heard best at the apex may be appreciated 
in the presence significant mitral insufficiency. Signs of heart failure may be present in cases 
with severe mitral insufficiency. 
3.2 Noninvasive evaluation 
3.2.1 Chest x-ray  
Chest film usually reveals mild to moderate cardiomegaly, prominent main pulmonary 
artery segment and increased pulmonary vascular markings. In the presence of significant 
mitral insufficiency, the cardiomegaly may be more prominent. 
3.2.2 Electrocardiogram  
Prolongation of PR interval (first degree heart block) is commonly seen. Right atrial, left 
atrial or biatrial enlargement is seen nearly half of the patients. The ECG also shows mild 
right ventricular hypertrophy; the so-called diastolic volume overload pattern with rsR' 
pattern in the right chest leads. Left ventricular hypertrophy may be seen if there is 
significant mitral insufficiency. Characteristically, the mean frontal plane vector is oriented 
superiorly between -300 and -900, the so called left axis deviation and this is typical for 
endocardial cushion defects. 
 
 
 
Fig. 7. An electrocardiogram of a child with ostium primum atrial septal defect 
demonstrating left axis deviation (-450 - deep S waves in leads II, III and AVF), right atrial 
enlargement (tall P waves in leads I and V2) and right ventricular hypertrophy (tall R waves 
in lead V2 and deep S waves in leads V5 and V6). 
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3.2.3 Echocardiogram  
Echocardiographic studies reveal enlarged right ventricle with paradoxical septal motion, 
particularly well-demonstrable on M-mode echocardiograms in patients with moderate to 
large ASDs. By two-dimensional echocardiogram, the defect can be clearly visualized 
(Figure 4). The type of ASD, secundum versus primum can also be delineated by the 
echocardiographic study (Figure 3 & 4). Demonstration of flow across the defect with color 
Doppler (Figure 8) echocardiography is possible. Cleft in the mitral valve may be 
demonstrated in precordial short axis views and mitral insufficiency jet may be shown in 
four chamber views (Figure 8). 
 
 
Fig. 8. Four chambered view of the heart demonstrates left-to-right shunt (red flow) across 
the ostium primum atrial septal defect (short arrow). Also note mitral insufficiency  
(long arrow).  
3.2.4 Other imaging studies 
Other imaging studies such as three-dimensional echo, MRI and CT may also demonstrate 
the defects, but are not necessary for routine cases. 
3.3 Catheterization and angiography 
Clinical and echocardiographic features are characteristic for the defect and cardiac 
catheterization is not necessary for the diagnosis. If pulmonary hypertension is suspected or 
if there are issues that can't be resolved by echocardiography, catheterization may be 
undertaken. 
If catheterization is performed, step-up in oxygen saturation at the right atrial level is seen. 
The left heart saturations are within normal range. Because the defects are usually large, the 
mean pressures in both atria are equal. The right ventricular and pulmonary arterial 
pressures are usually normal during childhood. The left heart pressures are also normal 
unless there is left ventricular outflow tract obstruction. Calculated pulmonary-to-systemic 
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flow ratio (Qp:Qs) is used to quantify the degree of shunting and the Qp:Qs is usually in 
excess of 2:1. Pulmonary vascular resistance is usually normal. 
Selective left ventricular cineangiography reveals a long and narrow left ventricular outflow 
tract resulting in what is described as goose-neck deformity, characteristic of endocardial 
cushion defects.  
3.4 Management 
The management of ostium primum ASD patients is largely dependent of the age at 
presentation and presence of symptoms, particularly those of congestive heart failure.  
3.4.1 Medical management 
Congestive heart failure is rare with ostium primum ASDs, although failure symptoms may 
be present in the presence of significant mitral insufficiency. In these patients anti-
congestive measures (diuretics and digoxin) should be instituted. If they do not improve, 
surgical closure should be considered. 
Transcatheter occlusion, now a standard treatment for ostium secundum ASDs, is not 
feasible in patients with ostium primum ASDs because there are no inferior septal rims, but 
more importantly because the need for addressing mitral valve cleft and the accompanying 
mitral insufficiency. 
SBE prophylaxis is recommended and normal activity is permitted in the absence of severe 
mitral insufficiency.  
3.4.2 Indications for closure 
Although surgical correction can be performed at any age, surgery in asymptomatic patients 
is usually recommended at the age of 3 to 4 years. In the presence of symptoms or if there is 
associated severe mitral insufficiency, surgical repair may be performed at presentation, 
after medically controlling the heart failure.  
3.4.3 Surgical management 
The conventional treatment of choice of ostium primum ASDs is surgical correction. Under 
general anesthesia, a median sternotomy incision is made, the aorta and vena cavae are 
cannulated and the patient placed on cardiopulmonary bypass. Right atriotomy is made and 
the defect and mitral valve are exposed. Closure of the mitral valve cleft with interrupted 
suture material and additional reparative procedures to address observed mitral valve 
abnormalities (for example, annuloplasty) should be undertaken. Then the atrial defect is 
closed using an autologous pericardial patch and rarely other prosthetic material (Dacron or 
Gore-Tex). Associated ostium secundum ASD or a patent foramen ovale should also be 
surgically closed at the same sitting. 
3.4.4 Results 
Results are generally good with a mortality rate less than 3%. The risk factors for poor 
results are severe mitral insufficiency, failure to thrive and congestive heart failure.  
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3.5 Prognosis 
The prognosis is generally good. The actuarial survival at 20- and 40-year follow-up was 
87% and 76% respectively for a large group of patients that had repair of ostium primum 
ASDs at Mayo Clinic (El-Najdawi et al 2000). The survival was better if the mitral valve 
repair was performed prior to 20 years of age. Repeat surgery, mostly to address mitral 
valve disease was required in 11% patients. Development of sub-aortic stenosis and heart 
block, requiring intervention occurs in a minority of patents during long-term follow-up. 
4. Sinus venosus ASDs 
Sinus venosus defects constitute 5 to 10% of all ASDs and the majority of defects are located 
in the posterior superior portion of the inter-atrial septum, often overriding the superior 
vena caval orifice. These defects are frequently associated with anomalous connection of the 
right upper pulmonary veins to the superior vena cava or right atrium near the cavo-atrial 
junction. The right pulmonary veins from the entire right lung may be connected 
anomalously. Rarely, the defect may be located in the inferior-posterior part of the atrial 
septum, overriding the inferior vena caval orifice. The dilatation of right heart structures is 
similar to that described in ostium secundum ASDs as are the clinical features. The ECG, in 
addition to the findings of rsR' pattern of the QRS complex shows somewhat superiorly 
oriented P wave vector (<300). Echocardiogram shows right ventricular volume overloading, 
similar to ostium secundum ASDs, but without an obvious ASD in the secondum position. 
Subcostal views may show the defect. Turbulence in the right upper pulmonary veins may 
also help suspect this diagnosis. The indications for intervention are also similar to those 
discussed in the ostium secundum ASD section. However, these defects are not amenable to 
transcatheter closure and surgical correction is the treatment of choice. Diversion of the 
anomalously connected right pulmonary vein(s) into the left atrium along with the closure 
of the ASD should be undertaken. This may involve constructing a tunnel with an 
autologous pericardial patch along with enlargement of superior vena cava. 
5. Coronary sinus ASDs 
These are rarest types of ASDs; these are defects in the inferior and anterior portion of the 
atrial septum at the expected location of the orifice of the coronary sinus. These defects are 
often associated with a persistent left superior vena cava and unroofing of the coronary 
sinus, a complex described as Raghib syndrome. The defect may be seen in association with 
asplenia syndrome. Dilatation of right heart structures and clinical features are similar to 
that described in ostium secundum ASD section. Echocardiogram is useful in the evaluation 
and diagnosis of this anomaly. Surgical correction with patch closure of the defect, leaving 
the entry of coronary sinus in the left atrium is the conventional method of approach (Lee 
and Sade 1979). These defects are not usually amenable to transcatheter closure. However, 
some, particularly small, defects may be amenable to transcatheter occlusion (Di Bernardo et 
al 2003) 
6. Patent foramen ovale 
To complete the discussion of defects in the atrial septum, a brief review of PFO is in order. 
The foramen ovale in the fetus is kept patent because of the mechanical effect of streaming 
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of the inferior vena caval blood into the left atrium. At birth, a combination of increase in the 
left atrial pressure secondary to increased pulmonary venous return and decrease in the 
right atrial pressure due to eliminated placental return will result in apposition of the 
septum primum and septum secundum causing functional closure of the foramen ovale. 
Eventually anatomical closure occurs in most normal individuals.  
Continued patency of the foramen ovale is critical in neonates with right heart obstructive 
lesions (tricuspid or pulmonary atresia) as well as left-sided obstructive lesions (hypoplastic 
left heart syndrome and mitral or aortic atresia) so as to allow an obligatory right-to-left or 
left-to-right shunt across the atrial septum, respectively. Similarly the patency of the 
foramen ovale is important in total anomalous pulmonary venous connection where all 
pulmonary and systemic venous returns come into the right atrium and consequently the 
systemic blood flow is entirely derived from right-to-left shunting across the PFO. In 
neonates with transposition of the great arteries (TGA), the circulation is parallel (instead of 
normal in-series circulation) and some inter-circulatory mixing is essential for survival; this 
is usually provided by the ASD/PFO. With any of the above scenarios the foramen ovale 
can become restrictive and may need enlargement either by transcatheter or surgical 
methodology (Rao 2007). 
In patients with large patent ductus arteriosus (PDA) or ventricular septal defect (VSD), the 
pulmonary blood flow is markedly increased with consequent increase in the left atrial size; 
this left atrial enlargement may cause stretching of the patent foramen ovale resulting in an 
additional left-to-right atrial shunting. However, in clinical practice, the clinician needs to 
address the primary cardiac problem (PDA or VSD) and the PFO will either spontaneously 
resolve or become small so that it may not remain clinically significant.  
The prevalence of PFO, based on autopsy studies is 27%; this incidence was 34% in the first 
thirty years of life which decreased to 25% in 30 to 80 year-olds which further decreased to 
20% in 80 to 100-year-olds (Hagen 1984). Similar prevalence was observed by TEE 
examinations. Consequently the PFO should be considered a normal variant. However, 
some these PFOs are considered to be the seat of right to left shunt causing paradoxical 
embolism and cerebrovascular accidents (Lechat et al 1988, Webster et al 1988, Ende et al 
1996, Windecker and Meier 2003) and hypoxemia as seen in platypnea-orthodeoxia 
syndrome (Waight  et al 2000, Rao et al 2001). Right to left shunt thru’ PFO can also occur in 
patients who were previously treated for complex congenital cardiac anomalies (Rao et al 
1997), including Fontan fenestrations as well as in patients who had right ventricular 
infarction (Bassi et al 2005). Decompression (Caisson’s) illness (Wilmshurst et al 1996, Walsh 
et al 1999, Wilmshurst et al 2000) and migrane (Wilmshurst et al 2000) have also been 
attributed to right to left shunt across PFO. There is varying degrees of evidence regarding 
the benefits of transcatheter occlusion of PFOs in above described conditions; some of these 
issues are addressed in later chapters of this book. 
7. Summary and conclusions 
In this review, the clinical features and management of ASDs are discussed. Four types of 
defects namely, ostium secondum, ostium primum, sinus venosus and coronar sinus ASDs 
are included. Patients with small defects, especially in childhood, are usually asymptomatic 
while moderate to large defects in infancy, though rarely, may present with symptoms. 
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Physical findings include hyperdynamic precordium, widely split and fixed second heart 
sound, ejection systolic murmur at the left upper sternal border and a mid-diastolic flow 
rumble at the left lower sternal border. Clinical diagnosis is not usually difficult and the 
diagnosis can be confirmed and quantified by non-invasive echocardiographic studies. 
Whereas surgical intervention was used in the past, transcatheter methods are currently 
used for closure of ostium secondum ASDs. Surgical correction is usually necessary for the 
other three types of defects.  
PFO is present in nearly one third of normal population and is likely to be a normal variant. 
In the presence of some structural abnormalities of the heart, their presence may facilitate 
intra-cardiac shunt to allow appropriate egress and/or mixing of blood flow. PFOs, 
presumed to be the seat of paradoxical embolism resulting in stroke/transient ischemic 
attacks deserve special consideration. Hypoxemia in post-surgical residual defects including 
Fontan fenestrations and right ventricular infarction may be secondary to right to left shunt 
across PFO. Other problems such as migraine, Caisson’s disease and platypnea-orthodexia 
syndrome are also attributed to shunts across PFO. Evidence for benefit of transcatheter 
occlusion of these PFOs is variable.  
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